From: COVID-19-associated coagulopathy: thromboembolism prophylaxis and poor prognosis in ICU
Characteristics | VTE | non-VTE | P value | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Age | 0.353 | ||||
<60 | 7 | 26.92 | 4 | 15.38 | |
≥60 | 12 | 46.15 | 3 | 11.54 | |
Sex | 0.186 | ||||
Male | 11 | 42.31 | 6 | 23.08 | |
Female | 8 | 30.77 | 1 | 3.85 | |
Cancer history | 0.444 | ||||
Yes | 1 | 3.85 | 1 | 3.85 | |
No | 18 | 69.23 | 6 | 23.08 | |
Diabetes history | 0.444 | ||||
Yes | 1 | 3.85 | 1 | 3.85 | |
No | 18 | 69.23 | 6 | 23.08 | |
VTE history | 0.536 | ||||
Yes | 1 | 3.85 | 0 | 0.00 | |
No | 18 | 69.23 | 7 | 26.92 |